Abstract |
Cancer therapy reduces tumor burden by killing tumor cells, yet it simultaneously creates tumor cell debris that may stimulate inflammation and tumor growth. Thus, conventional cancer therapy is inherently a double-edged sword. In this study, we show that tumor cells killed by chemotherapy or targeted therapy (" tumor cell debris") stimulate primary tumor growth when coinjected with a subthreshold (nontumorigenic) inoculum of tumor cells by triggering macrophage proinflammatory cytokine release after phosphatidylserine exposure. Debris-stimulated tumors were inhibited by antiinflammatory and proresolving lipid autacoids, namely resolvin D1 (RvD1), RvD2, or RvE1. These mediators specifically inhibit debris-stimulated cancer progression by enhancing clearance of debris via macrophage phagocytosis in multiple tumor types. Resolvins counterregulate the release of cytokines/ chemokines, including TNFα, IL-6, IL-8, CCL4, and CCL5, by human macrophages stimulated with cell debris. These results demonstrate that enhancing endogenous clearance of tumor cell debris is a new therapeutic target that may complement cytotoxic cancer therapies.
|
Authors | Megan L Sulciner, Charles N Serhan, Molly M Gilligan, Dayna K Mudge, Jaimie Chang, Allison Gartung, Kristen A Lehner, Diane R Bielenberg, Birgitta Schmidt, Jesmond Dalli, Emily R Greene, Yael Gus-Brautbar, Julia Piwowarski, Tadanori Mammoto, David Zurakowski, Mauro Perretti, Vikas P Sukhatme, Arja Kaipainen, Mark W Kieran, Sui Huang, Dipak Panigrahy |
Journal | The Journal of experimental medicine
(J Exp Med)
Vol. 215
Issue 1
Pg. 115-140
(01 02 2018)
ISSN: 1540-9538 [Electronic] United States |
PMID | 29191914
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 Sulciner et al. |
Chemical References |
- Antineoplastic Agents
- Cytokines
- Inflammation Mediators
- Phosphatidylserines
- Docosahexaenoic Acids
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Cell Proliferation
- Cytokines
(metabolism)
- Disease Models, Animal
- Docosahexaenoic Acids
(pharmacology)
- Humans
- Inflammation Mediators
(metabolism)
- Macrophages
(metabolism)
- Melanoma, Experimental
- Mice
- Mice, Knockout
- Mice, Transgenic
- Neoplasms
(drug therapy, metabolism, pathology)
- Phagocytosis
- Phosphatidylserines
(metabolism)
- Tumor Burden
- Xenograft Model Antitumor Assays
|